Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis
PaperCitations, authors & open-access status
Vandetanib (ZD6474): an orally available receptor tyrosine kinase inhibitor that selectively targets pathways critical for tumor growth and angiogenesis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 144 citations, 2007 year and closed oa status.
144
Citations
2007
Year
closed
OA Status